RT Journal Article
SR Electronic
T1 Suicide and mental health during the COVID-19 pandemic in Japan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.06.20207530
DO 10.1101/2020.10.06.20207530
A1 Michiko Ueda
A1 Robert Nordström
A1 Tetsuya Matsubayashi
YR 2020
UL http://medrxiv.org/content/early/2020/12/20/2020.10.06.20207530.abstract
AB Background The coronavirus disease (COVID-19) pandemic is an unprecedented public health crisis, but its effect on suicide deaths is little understood.Methods We analyzed data from monthly suicide statistics between January 2017 and October 2020 and from online surveys on mental health filled out by the general population in Japan.Results Compared to the last three years (2017-2019), the number of suicide deaths was lower than average during the initial phase of the pandemic but exceeded the past trend starting in July 2020. The source of the increase was mainly female suicides whose numbers increased by approximately 70% in October 2020 (IRR: 1.695, 95% CI: 1.558-1.843). The largest increase was found among young women (less than 40 years of age). Our survey data indicated that the status of mental health among young women has been deteriorating in recent months, and that young female workers were more likely than any other group to have experienced a job or income loss, suggesting adverse economic conditions surrounding some of these individuals.Conclusions Our results indicate that continuous monitoring of mental health, particularly that of the most vulnerable populations identified in this study, and appropriate suicide prevention efforts are necessary during the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financially supported by JSPS Grants-in-Aid for Scientific Research Grant Number 20H01584. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The survey was approved by the Ethics Review Committee on Human Research of Waseda University (approval #: 2020-050) and Osaka School of International Public Policy, Osaka University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data on suicide deaths are public data. The individual survey data cannot be shared due to the sensitive nature of the study.